Phase II window studies: 10 years of experience and counting.
Smith
M A
MA
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA.
Anderson
B
B
D000293:Adolescent; D000328:Adult; D001859:Bone Neoplasms / Q000188:drug therapy*; D002648:Child; D017322:Clinical Trials, Phase II as Topic / Q000379:methods* / Q000592:standards; D006801:Humans; D012516:Osteosarcoma / Q000188:drug therapy*; D012107:Research Design / Q000592:standards; D012208:Rhabdomyosarcoma / Q000188:drug therapy*